BCLSI

Bain Capital Life Sciences Investors Portfolio holdings

AUM $1.31B
1-Year Est. Return 142.79%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+142.79%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.31B
AUM Growth
-$201M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
21
New
Increased
Reduced
Closed

Top Buys

1
+$29.6M
2
+$20.1M
3
+$14.4M
4
XLO icon
Xilio Therapeutics
XLO
+$2.11M

Top Sells

1
+$289M
2
+$124M
3
+$27.6M
4
DNTH icon
Dianthus Therapeutics
DNTH
+$22.2M
5
TNGX icon
Tango Therapeutics
TNGX
+$17.7M

Sector Composition

1 Healthcare 99.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HTFL
1
Heartflow Inc
HTFL
$2.26B
$363M 27.79%
12,448,158
NAMS icon
2
NewAmsterdam Pharma
NAMS
$3.32B
$256M 19.63%
7,306,566
-3,412,544
OLMA icon
3
Olema Pharmaceuticals
OLMA
$1.25B
$213M 16.29%
8,508,641
+1,664,687
SVRA icon
4
Savara
SVRA
$1.04B
$106M 8.13%
17,600,621
PHVS icon
5
Pharvaris
PHVS
$1.73B
$77.8M 5.96%
2,802,081
-379,194
SLDB icon
6
Solid Biosciences
SLDB
$554M
$44.6M 3.42%
7,911,669
UPB
7
Upstream Bio Inc
UPB
$471M
$36.1M 2.76%
1,329,544
-1,109,994
XFOR icon
8
X4 Pharmaceuticals
XFOR
$383M
$31.9M 2.44%
7,967,454
+5,530,866
DNTH icon
9
Dianthus Therapeutics
DNTH
$3.41B
$30.6M 2.35%
743,592
-572,300
KYTX icon
10
Kyverna Therapeutics
KYTX
$459M
$29.2M 2.24%
3,110,000
-258,370
ANNX icon
11
Annexon
ANNX
$784M
$26.4M 2.02%
5,249,069
RPID icon
12
Rapid Micro Biosystems
RPID
$108M
$24.5M 1.87%
8,434,560
CABA icon
13
Cabaletta Bio
CABA
$266M
$21.2M 1.62%
9,677,125
CCCC icon
14
C4 Therapeutics
CCCC
$258M
$13.7M 1.05%
7,171,910
+6,060,000
MRSN
15
DELISTED
Mersana Therapeutics
MRSN
$10M 0.77%
346,545
AVIR icon
16
Atea Pharmaceuticals
AVIR
$444M
$8.87M 0.68%
2,485,638
TNGX icon
17
Tango Therapeutics
TNGX
$2.8B
$5.79M 0.44%
653,493
-2,058,515
XLO icon
18
Xilio Therapeutics
XLO
$583M
$4.72M 0.36%
7,372,686
+2,805,869
NAMSW icon
19
NewAmsterdam Pharma Warrant
NAMSW
$89.7M
$2.3M 0.18%
99,999
-1
CDTX
20
DELISTED
Cidara Therapeutics
CDTX
– –
-3,020,990
IPSC icon
21
Century Therapeutics
IPSC
$408M
– –
-3,538,609